Sports Physical Therapy — Neuromuscular and Proprioceptive Training in Football Players
Citation(s)
Carter CW, Micheli LJ Training the child athlete: physical fitness, health and injury. Br J Sports Med. 2011 Sep;45(11):880-5. doi: 10.1136/bjsports-2011-090201. Review.
DiFiori JP Evaluation of overuse injuries in children and adolescents. Curr Sports Med Rep. 2010 Nov-Dec;9(6):372-8. doi: 10.1249/JSR.0b013e3181fdba58.
Franklin CC, Weiss JM Stopping sports injuries in kids: an overview of the last year in publications. Curr Opin Pediatr. 2012 Feb;24(1):64-7. doi: 10.1097/MOP.0b013e32834ec618. Review.
Hewett TE, Ford KR, Hoogenboom BJ, Myer GD Understanding and preventing acl injuries: current biomechanical and epidemiologic considerations - update 2010. N Am J Sports Phys Ther. 2010 Dec;5(4):234-51.
Hill DE, Andrews JR Stopping sports injuries in young athletes. Clin Sports Med. 2011 Oct;30(4):841-9. doi: 10.1016/j.csm.2011.07.003.
Leininger RE, Knox CL, Comstock RD Epidemiology of 1.6 million pediatric soccer-related injuries presenting to US emergency departments from 1990 to 2003. Am J Sports Med. 2007 Feb;35(2):288-93. Epub 2006 Nov 7.
Nettle H, Sprogis E Pediatric exercise: truth and/or consequences. Sports Med Arthrosc Rev. 2011 Mar;19(1):75-80. doi: 10.1097/JSA.0b013e318209cf2b. Review.
Schub D, Saluan P Anterior cruciate ligament injuries in the young athlete: evaluation and treatment. Sports Med Arthrosc Rev. 2011 Mar;19(1):34-43. doi: 10.1097/JSA.0b013e31820b960d. Review.
Effect of Neuromuscular and Proprioceptive Training in Reducing Landing Error Patterns in Football Players
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
